BioCentury
ARTICLE | Company News

Takeda, UCL deal

November 9, 2015 8:00 AM UTC

Takeda partnered with the University College London to identify and validate novel target genes to treat neurodegenerative disease. Under the three-year deal, the partners will focus on mechanistic approaches to identify genes or signaling pathways that modify neurodegenerative disease processes affecting neuronal health, including Huntington’s and Parkinson’s disease. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article